Can Roche Retain Genentech’s Top Talent?

We explained yesterday how Genentech, now the target of a takeover bid from Roche, has in many ways become a Big Pharma company. But as Genentech’s master after a full-blown buyout, Roche would face a huge challenge: Hanging on to Genentech’s biotech talent. Happier days for Arthur Levinson, CEO of Genentech, and Richard Grasso, New York [...]